Meta-analysis of Per-Day Step Count and All-Cause Mortality

Ameesh Isath,Salim S. Virani,Zhen Wang,Carl J. Lavie,Srihari S. Naidu,Franz H. Messerli,Chayakrit Krittanawong
DOI: https://doi.org/10.1016/j.amjcard.2022.06.056
IF: 3.133
2022-01-01
The American Journal of Cardiology
Abstract:The beneficial effect of physical activity (PA) on cardiovascular disease (CVD) has been well established. 1 Bull FC Al-Ansari SS Biddle S Borodulin K Buman MP Cardon G Carty C Chaput JP Chastin S Chou R Dempsey PC DiPietro L Ekelund U Firth J Friedenreich CM Garcia L Gichu M Jago R Katzmarzyk PT Lambert E Leitzmann M Milton K Ortega FB Ranasinghe C Stamatakis E Tiedemann A Troiano RP van der Ploeg HP Wari V Willumsen JF. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020; 54: 1451-1462 Crossref PubMed Scopus (3334) Google Scholar Walking is ubiquitous and central to PA, requires no specialized training, and can be easily monitored. The number of steps per day (SPD) can be used as a simple correlate of PA, and with the expansion of wearable step monitors and smartphones with activity tracking, quantification of SPD also has become readily feasible and widely popular. In terms of target SPD, a 10,000-step goal has been advocated with limited evidence. The objective of this systematic review and meta-analysis was therefore to explore the association between SPD and CVD events.
What problem does this paper attempt to address?